HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Saks appoints Clairol exec

This article was originally published in The Rose Sheet

Executive Summary

Bristol-Myers Squibb Senior VP Stephen Sadove joins retailer's management team as vice chairman, Saks Fifth Avenue announces. Exec will be responsible for operating plans, performance management and identification of brand extensions and new business opportunities, company says. Sadove worked most recently at BMS as president of worldwide beauty care and nutritionals. Exec joined BMS in 1991 as Clairol president and became president of worldwide beauty care in 1996. Under Sadove, BMS sold its Clairol hair care business to Procter & Gamble (1"The Rose Sheet" May 28, 2001, p. 3)...

You may also be interested in...



Clairol $50 Mil. Marketing Boost Part Of P&G Blueprint For Growth

Procter & Gamble plans to increase marketing spending on Clairol by approximately $50 mil. within its first year of acquiring the hair care business to "restore competitive marketing," President and CEO A.G. Lafley said during a May 21 analyst meeting outlining plans for the purchase.

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS009949

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel